You are viewing the site in preview mode

Skip to main content

Table 2 Item selection

From: IDentification of patients in need of general and specialised PALLiative care (ID-PALL©): item generation, content and face validity of a new interprofessional screening instrument

ItemsRound 1 M ± SD; N = 36Round 2 M ± SD; N = 31
General PC
 Surprise question 12 months4.1 ± 1.4; n = 20 
 Surprise question 6 months5.0 ± 0.0; n = 3 
 Surprise question months, weeks or days4.2 ± 0.8; n = 5 
 PC required by healthcare professional3.2 ± 1.8; n = 64.3 ± 1.0; n = 7
 PC required implicitly or explicitly by patients or relatives3.5 ± 1.3; n = 19 
 PC required by patients/relatives3.3 ± 1.4; n = 6 
 Advanced illness, unstable symptoms3.8 ± 1.6; n = 5 
 Advanced illness and/or diminishing response to aetiological treatments4.3 ± 0.5; n = 8 
 Disease that cannot be treated, vital prognosis is underway4.0 ± 1.3; n = 16 
 Decreased response to treatment1.7 ± 0.6; n = 3 
 At least one disturbing symptom2.6 ± 0.9; n = 114.1 ± 0.8; n = 11
 Decrease in general condition3.2 ± 1.3; n = 64.8 ± 0.5; n = 4
 Poor or deteriorating performance status2.6 ± 0.8; n = 73.8 ± 0.8; n = 9
 General functional decline1.9 ± 0.8; n = 85.0 ± 0.0; n = 8
 Functional markers of decline2.5 ± 0.6; n = 4 
 Dependency on others for most care needsn = 0 
 Nutritional markers of decline1.8 ± 0.7; n = 84.0 ± 0.6; n = 4
 Significant weight loss2.0 ± 0.8; n = 4 
 Interruption of any vital support measures2.7 ± 0.8; n = 64.0 ± 0.8; n = 11
 Other markers of severity and extreme fragility2.0 ± 1.0; n = 123.7 ± 0.7; n = 9
 Sentinel eventsn = 0 
  ≥ 2 unscheduled hospitalizations1.8 ± 1.0; n = 93.9 ± 0.8; n = 9
  ≥ 2 concomitant diseasesn = 0 
 Significant co-morbidity2.0 ± 1.1; n = 73.7 ± 0.9; n = 9
 Emotional distress1.8 ± 0.7; n = 83.7 ± 0.8; n = 6
Specialised PC
 Specific population4.1 ± 1.1; n = 113.6 ± 1.6; n = 8
 Rapidly evolving illness3.2 ± 1.8; n = 53.8 ± 1.7; n = 8
 Need for complex and intense continuing care3.0 ± 1.5; n = 122.3 ± 1.0; n = 9
 Persistent and distressing symptoms4.4 ± 0.6; n = 27 
  ≥ 3 symptoms > 5 on ESAS3.8 ± 1.5; n = 83.6 ± 1.5; n = 10
 Uncontrolled pain3.2 ± 1.2; n = 94.3 ± 0.9; n = 16
 Difficulties in assessing symptoms3.8 ± 0.9; n = 183.5 ± 1.1; n = 15
 Severe psychological and/or existential distress2.6 ± 1.0; n = 182.6 ± 1.2; n = 17
 Request for assisted suicide or euthanasia1.4 ± 1.1; n = 82.2 ± 1.5; n = 6
 Psychosocial distress patient and/or relatives2.5 ± 0.9; n = 173.0 ± 1.1; n = 11
 Difficulties in integrating information about the  disease and/or prognosis1.0 ± 0.0; n = 1 
 Lack or insufficient support from relatives2.0 ± 1.0; n = 3 
 Social vulnerability2.0 ± 0.0; n = 1 
 Accompanying the patient is difficult1.4 ± 0.8; n = 7 
 Difficulties in communicating about therapeutic/care objectives1.8 ± 0.4; n = 62.0 ± 1.4; n = 8
 Significant disagreement, uncertainty or conflict2.5 ± 1.5; n = 212.8 ± 1.4; n = 22
 Need for support and/or second opinion for current decision-making1.9 ± 0.8; n = 9 
 Difficulties in writing advanced directivesn = 0 
 Specialised PC team required by healthcare professional 3.6 ± 1.3; n = 5
 Palliative sedation envisaged 2.6 ± 1.3; n = 14
 Need for respite for the relatives 1.3 ± 0.6; n = 3